Tag archive for ‘Ron Babecoff’
Jewish Business News On Monday, January 2nd, 2017

BiondVax Receives $2.8 million Investment from Marius Nacht fund

  BiondVax Pharmaceuticals Ltd. has announce that Angels High Tech Investments Ltd. has agreed to invest NIS 10.9 million, (approx $2.83 million), in exchange for 33.8 million ordinary BiondVax shares More...

Jewish Business News On Monday, August 3rd, 2015

Independent Results: BiondVax’s Universal Flu Vaccine Administered in a Trial 3 years ago Improves Immunogenicity against Current Flu Vaccine

  BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV, TASE: BVXV) received the statistical analysis of results from a study which demonstrates that BiondVax’s universal flu vaccine (M-001), administered More...

Gil Tanenbaum On Wednesday, September 10th, 2014

Israeli BiondVax Gets $1.34 Million to Develop Universal Flu Vaccine

Israeli firm BiondVax, a biopharmaceutical company developing a Universal Flu Vaccine, has been awarded $1.34 million from Israel’s Chief Scientist in the Ministry of Economy to promote the company’s More...

Globes On Wednesday, July 31st, 2013

Israeli Weizmann Institute of Science R&D company earns $50-100 million annually

– Products developed by the Weizmann Institute have $20 billion in annual sales. – – / By Gali Weinreb / The campus of the Weizmann Institute of Science gives a sense of abundance to those More...

Wordpress site Developed by Fixing WordPress Problems